GAITHERSBURG, Md. (WJZ) — The Gaithersburg-based company Novavax announced it expects to file for approval of its COVID-19 vaccine candidate in December.

According to Reuters, the company plans to produce part of the vaccine at its Czech plant and give the country access to the product once its approved.


Earlier this week, Novavax announced it had started enrolling volunteers.

For the latest information on coronavirus go to the Maryland Health Department’s website or call 211. You can find all of WJZ’s coverage on coronavirus in Maryland here.


Leave a Reply